|
ZA847926B
(en)
*
|
1983-10-17 |
1986-05-28 |
Lilly Co Eli |
3-bicyclicpyridinium-methyl cephalosporins
|
|
US5468757A
(en)
*
|
1994-01-31 |
1995-11-21 |
Eli Lilly And Company |
6-azaindole thromboxane synthase inhibitors
|
|
JP2002528543A
(ja)
|
1998-10-30 |
2002-09-03 |
メルク エンド カムパニー インコーポレーテッド |
トロンビン阻害剤
|
|
US6420382B2
(en)
|
2000-02-25 |
2002-07-16 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
US6809105B2
(en)
|
2000-04-27 |
2004-10-26 |
Abbott Laboratories |
Diazabicyclic central nervous system active agents
|
|
CA2707827A1
(en)
*
|
2001-04-11 |
2002-10-24 |
Senju Pharmaceutical Co., Ltd. |
Visual function disorder improving agents containing rho kinase inhibitors
|
|
AR036040A1
(es)
|
2001-06-12 |
2004-08-04 |
Upjohn Co |
Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
|
|
EP1432707B1
(en)
|
2001-10-02 |
2012-03-28 |
Pharmacia & Upjohn Company LLC |
Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
|
|
US6849620B2
(en)
|
2001-10-26 |
2005-02-01 |
Pfizer Inc |
N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
|
|
CA2477967C
(en)
|
2002-03-05 |
2010-08-10 |
Eli Lilly And Company |
Purine derivatives as kinase inhibitors
|
|
KR20050004214A
(ko)
|
2002-05-31 |
2005-01-12 |
에자이 가부시키가이샤 |
피라졸 화합물 및 이것을 포함하여 이루어지는 의약 조성물
|
|
WO2004039366A1
(en)
|
2002-11-01 |
2004-05-13 |
Pharmacia & Upjohn Company Llc |
Nicotinic acetylcholine agonists in the treatment of glaucoma and retinal neuropathy
|
|
CA2503786A1
(en)
|
2002-11-01 |
2004-05-13 |
Pharmacia & Upjohn Company Llc |
Compounds having both alpha7 nicotinic agonist activity and 5ht, antagonist activity for treatment of cns diseases
|
|
WO2004052348A2
(en)
|
2002-12-11 |
2004-06-24 |
Pharmacia & Upjohn Company Llc |
Treatment of diseases with combinations of alpha 7 nicotinic acetylcholine receptor agonists and other compounds
|
|
CN1735441A
(zh)
|
2002-12-11 |
2006-02-15 |
法玛西亚普强责任有限公司 |
治疗注意缺陷多动症的组合
|
|
BRPI0406834A
(pt)
|
2003-01-22 |
2005-12-27 |
Pharmacia & Upjohn Co Llc |
Tratamento de doença com agonistas totais do receptor nach alfa-7
|
|
EP1706384A1
(en)
|
2004-01-07 |
2006-10-04 |
AstraZeneca AB |
Therapeutic agents i
|
|
EP1768979B1
(en)
|
2004-07-21 |
2010-09-29 |
Merck Serono SA |
Octahydropyrrolo[2, 3, c]pyridine derivatives and pharmaceutical use thereof
|
|
DK1784404T3
(da)
|
2004-09-03 |
2012-02-13 |
Yuhan Corp |
Pyrrolo[2,3-c]pyridinderivater samt fremgangsmåder til deres fremstilling
|
|
CA2589127C
(en)
|
2004-12-08 |
2013-02-05 |
Johannes Gutenberg-Universitat Mainz |
3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors
|
|
EP1838706A1
(en)
|
2004-12-24 |
2007-10-03 |
Prosidion Limited |
G-protein coupled receptor agonists
|
|
US7557103B2
(en)
|
2005-04-05 |
2009-07-07 |
Eli Lilly And Company |
Imidazopyridazine compounds
|
|
US7777035B2
(en)
|
2005-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
Azaindazole compounds and methods of use
|
|
ZA200800309B
(en)
|
2005-06-22 |
2009-10-28 |
Chemocentryx Inc |
Azaindazole compounds and methods of use
|
|
KR101142363B1
(ko)
|
2005-06-27 |
2012-05-21 |
주식회사유한양행 |
피롤로피리딘 유도체를 포함하는 항암제 조성물
|
|
CN101003537A
(zh)
|
2006-01-17 |
2007-07-25 |
上海恒瑞医药有限公司 |
吡咯并哒嗪类衍生物及其制备方法和用途
|
|
GB0705803D0
(en)
|
2007-03-28 |
2007-05-02 |
Glaxo Group Ltd |
Novel compounds
|
|
DK2142516T3
(da)
|
2007-03-30 |
2013-04-15 |
Sanofi Sa |
Pyrimidinhydrazidforbindelser i ders egenskab af pgds-inhibitorer
|
|
JP2010524931A
(ja)
|
2007-04-16 |
2010-07-22 |
メルク・シャープ・エンド・ドーム・コーポレイション |
二環式アニリドヘテロ環式ｃｇｒｐ受容体アンタゴニスト
|
|
WO2009041567A1
(ja)
|
2007-09-27 |
2009-04-02 |
Banyu Pharmaceutical Co., Ltd. |
メラニン凝集ホルモン受容体拮抗作用を有するジアリールケチミン誘導体
|
|
GB0803018D0
(en)
|
2008-02-19 |
2008-03-26 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
|
CN104387382A
(zh)
|
2008-03-24 |
2015-03-04 |
梅迪维新技术公司 |
吡啶并[3,4-b]吲哚和应用方法
|
|
AR071717A1
(es)
|
2008-05-13 |
2010-07-07 |
Array Biopharma Inc |
Pirrolo[2,3-b]piridinas inhibidoras de quinasas chk1 y chk2,composiciones farmaceuticas que las contienen,proceso para prepararlas y uso de las mismas en el tratamiento y prevencion del cancer.
|
|
US8012992B2
(en)
|
2008-06-30 |
2011-09-06 |
Allergan, Inc. |
Aza-indoles and related compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
|
|
NZ590688A
(en)
|
2008-08-05 |
2012-09-28 |
Daiichi Sankyo Co Ltd |
imidazo[4,5-b]pyridin-2-one derivatives
|
|
JP5576370B2
(ja)
|
2008-08-06 |
2014-08-20 |
ファイザー・インク |
Ｃｈｋ−１阻害剤としての６置換２−ヘテロシクリルアミノピラジン化合物
|
|
US20110183975A1
(en)
|
2008-10-07 |
2011-07-28 |
Yasuhiro Goto |
Novel 6-azaindole aminopyrimidine derivatives having nik inhibitory activity
|
|
US8785489B2
(en)
|
2008-10-17 |
2014-07-22 |
Boehringer Ingelheim International Gmbh |
Heteroaryl substituted indole compounds useful as MMP-13 inhibitors
|
|
WO2010046780A2
(en)
|
2008-10-22 |
2010-04-29 |
Institut Pasteur Korea |
Anti viral compounds
|
|
CN101723936B
(zh)
|
2008-10-27 |
2014-01-15 |
上海睿星基因技术有限公司 |
激酶抑制剂及其在药学中的用途
|
|
PL3050874T3
(pl)
|
2008-11-14 |
2019-07-31 |
Merial Inc. |
Wzbogacone enancjomerycznie aryloazol-2-ilocyjanoetyloaminowe związki pasożytobójcze
|
|
WO2011096490A1
(ja)
|
2010-02-04 |
2011-08-11 |
第一三共株式会社 |
イミダゾピリジン－２－オン誘導体
|
|
JP2011178779A
(ja)
|
2010-02-04 |
2011-09-15 |
Daiichi Sankyo Co Ltd |
イミダゾピリジン−２−オン誘導体
|
|
JP2013519681A
(ja)
|
2010-02-11 |
2013-05-30 |
オーエスアイ・ファーマシューティカルズ，エルエルシー |
７−アミノフロピリジン誘導体
|
|
GB201017345D0
(en)
|
2010-10-14 |
2010-11-24 |
Proximagen Ltd |
Receptor antagonists
|
|
WO2012058645A1
(en)
|
2010-10-29 |
2012-05-03 |
Biogen Idec Ma Inc. |
Heterocyclic tyrosine kinase inhibitors
|
|
CN102464654B
(zh)
|
2010-11-12 |
2016-01-13 |
上海泓博智源医药技术有限公司 |
抗病毒化合物
|
|
TWI501967B
(zh)
|
2010-12-16 |
2015-10-01 |
Janssen R&D Ireland |
作為呼吸道融合病毒抗病毒劑之氮雜吲哚類
|
|
KR20140027090A
(ko)
|
2011-01-04 |
2014-03-06 |
노파르티스 아게 |
연령-관련 황반 변성 (amd)의 치료에 유용한 인돌 화합물 또는 그의 유사체
|
|
US9249087B2
(en)
|
2011-02-01 |
2016-02-02 |
The Board Of Trustees Of The University Of Illinois |
HDAC inhibitors and therapeutic methods using the same
|
|
DE102011009961A1
(de)
*
|
2011-02-01 |
2012-08-02 |
Merck Patent Gmbh |
7-Azaindolderivate
|
|
WO2012114252A1
(en)
|
2011-02-21 |
2012-08-30 |
Actelion Pharmaceuticals Ltd |
Novel indole and pyrrolopyridine amides
|
|
CN103534257A
(zh)
|
2011-04-05 |
2014-01-22 |
辉瑞有限公司 |
作为原肌球蛋白相关激酶抑制剂的吡咯并[2,3-d]嘧啶衍生物
|
|
WO2012178022A2
(en)
|
2011-06-24 |
2012-12-27 |
University Of Massachusetts |
Therapeutic applications targeting sarm1
|
|
UA111756C2
(uk)
|
2011-11-03 |
2016-06-10 |
Ф. Хоффманн-Ля Рош Аг |
Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
|
|
TWI577671B
(zh)
|
2011-11-14 |
2017-04-11 |
Sunshine Lake Pharma Co Ltd |
Aminoquinazoline derivatives and salts thereof and methods of use thereof
|
|
CN102532027A
(zh)
|
2012-03-01 |
2012-07-04 |
常州协丰医药研发有限公司 |
一种通过羟胺活化来形成吲唑衍生物的合成方法
|
|
CN102675310B
(zh)
|
2012-05-09 |
2014-12-24 |
林辉 |
制备吡唑并芳杂环化合物的方法
|
|
US20150336948A1
(en)
|
2012-05-29 |
2015-11-26 |
Merck Sharp & Dohme Corp. |
Isotopically Labeled Biaryl Urea Compounds
|
|
WO2014002053A1
(en)
|
2012-06-28 |
2014-01-03 |
Novartis Ag |
Pyrrolidine derivatives and their use as complement pathway modulators
|
|
EP2867229B1
(en)
|
2012-06-28 |
2017-07-26 |
Novartis AG |
Pyrrolidine derivatives and their use as complement pathway modulators
|
|
EP2872503B1
(en)
|
2012-07-12 |
2018-06-20 |
Novartis AG |
Complement pathway modulators and uses thereof
|
|
DK2877467T3
(en)
|
2012-07-26 |
2017-02-13 |
Glaxo Group Ltd |
2- (AZAINDOL-2-YL) BENZIMIDAZOLES AS PAD4 INHIBITORS
|
|
WO2014165143A1
(en)
|
2013-03-12 |
2014-10-09 |
Abbvie Inc. |
Dihydro-pyrrolopyridinone bromodomain inhibitors
|
|
TWI663166B
(zh)
|
2013-04-24 |
2019-06-21 |
健生藥品公司 |
新化合物
|
|
AP2015008843A0
(en)
|
2013-05-02 |
2015-11-30 |
Pfizer |
Imidazo-triazine derivatives as pde10 inhibitors
|
|
GB201310460D0
(en)
|
2013-06-12 |
2013-07-24 |
Lytix Biopharma As |
Compounds
|
|
FR3008975A1
(fr)
|
2013-07-23 |
2015-01-30 |
Servier Lab |
Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
KR20160118368A
(ko)
*
|
2014-02-25 |
2016-10-11 |
아칠리온 파르마세우티칼스 인코포레이티드 |
보체 매개된 장애의 치료를 위한 에터 화합물
|
|
JP6581111B2
(ja)
|
2014-04-28 |
2019-09-25 |
メッドシャイン ディスカバリー インコーポレイテッド |
Ｒｈｏキナーゼ阻害剤としてのイソキノリンスルホン誘導体
|
|
WO2015188368A1
(en)
|
2014-06-13 |
2015-12-17 |
Merck Sharp & Dohme Corp. |
Pyrrolo[2,3-c]pyridines as imaging agents for neurofibrilary tangles
|
|
EP3154974B1
(en)
|
2014-06-13 |
2018-11-14 |
Bristol-Myers Squibb Company |
Tricyclic compounds as alpha- 7 nicotinic acetylcholine receptor ligands
|
|
WO2015191403A1
(en)
|
2014-06-13 |
2015-12-17 |
Bristol-Myers Squibb Company |
Tricyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
|
CN111253424B
(zh)
|
2014-08-06 |
2023-06-20 |
加州理工学院 |
芳族杂环通过地球丰富的无过渡金属的催化剂的甲硅烷基化
|
|
ES2718557T3
(es)
|
2014-10-23 |
2019-07-02 |
Janssen Pharmaceutica Nv |
Nuevos compuestos como inhibidores de nik
|
|
BR112017007704B1
(pt)
|
2014-10-23 |
2023-04-11 |
Janssen Pharmaceutica N.V |
Derivados de pirazolopirimidina como inibidores de nik, seu uso e composição farmacêutica que os compreende
|
|
WO2016095089A1
(en)
|
2014-12-15 |
2016-06-23 |
Merck Sharp & Dohme Corp. |
Erk inhibitors
|
|
WO2016095088A1
(en)
|
2014-12-15 |
2016-06-23 |
Merck Sharp & Dohme Corp. |
Erk inhibitors
|
|
US9938276B2
(en)
|
2014-12-19 |
2018-04-10 |
Merck Sharp & Dohme Corp. |
6,5-bicyclic octahydropyrrolopyridine orexin receptor antagonists
|
|
WO2016161571A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
Indazole and azaindazole btk inhibitors
|
|
CN107635986A
(zh)
|
2015-05-13 |
2018-01-26 |
赛尔维他股份公司 |
取代的喹喔啉衍生物
|
|
CA2988436A1
(en)
|
2015-07-13 |
2017-01-19 |
Arvinas, Inc. |
Alanine-based modulators of proteolysis and associated methods of use
|
|
EP3331886B1
(en)
|
2015-08-05 |
2020-07-15 |
Indivior UK Limited |
Dopamine d3 receptor antagonists having a bicyclo moiety
|
|
AR106018A1
(es)
|
2015-08-26 |
2017-12-06 |
Achillion Pharmaceuticals Inc |
Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
|
|
AR105809A1
(es)
|
2015-08-26 |
2017-11-08 |
Achillion Pharmaceuticals Inc |
Compuestos para el tratamiento de trastornos médicos
|
|
EP3340982B1
(en)
|
2015-08-26 |
2021-12-15 |
Achillion Pharmaceuticals, Inc. |
Compounds for treatment of immune and inflammatory disorders
|
|
EP3389664A4
(en)
|
2015-12-14 |
2020-01-08 |
Raze Therapeutics Inc. |
MTHFD2 CAFFEINE INHIBITORS AND USE THEREOF
|
|
TWI726968B
(zh)
|
2016-01-07 |
2021-05-11 |
開曼群島商Ｃｓ醫藥技術公司 |
Egfr酪胺酸激酶之臨床重要突變體之選擇性抑制劑
|
|
TWI747873B
(zh)
|
2016-02-01 |
2021-12-01 |
美商百歐克斯製藥公司 |
苯并吡唑化合物及其類似物
|
|
CA3025220A1
(en)
|
2016-05-24 |
2017-11-30 |
Merck Patent Gmbh |
Tricyclic heterocylic derivatives
|
|
US20170355708A1
(en)
|
2016-06-09 |
2017-12-14 |
Cadent Therapeutics, Inc. |
Potassium channel modulators
|
|
EP3481391A4
(en)
|
2016-07-11 |
2020-03-11 |
Lifesci Pharmaceuticals, Inc. |
THERAPEUTIC INHIBITOR COMPOUNDS
|
|
WO2018035204A1
(en)
|
2016-08-16 |
2018-02-22 |
Henry Ford Health System |
Compositions for the treatment of neuropathic pain and sensitization of tumors to chemotherapies
|
|
IL292977A
(en)
|
2016-09-09 |
2022-07-01 |
Incyte Corp |
Pyrazolopyridine derivatives as modulators of hpk1 and their use in cancer therapy
|
|
WO2018057989A1
(en)
|
2016-09-24 |
2018-03-29 |
Washington University |
INHIBITORS OF SARM1 NADase ACTIVITY AND USES THEREOF
|
|
CN115448916B
(zh)
|
2016-10-14 |
2026-04-28 |
武田药品工业株式会社 |
Tyk2抑制剂及其用途
|
|
UA125302C2
(uk)
|
2016-11-02 |
2022-02-16 |
Янссен Фармацевтика Нв |
Похідні [1,2,4]триазоло[1,5-a]піримідину як інгібітори pde2
|
|
WO2018149986A1
(en)
|
2017-02-16 |
2018-08-23 |
Oryzon Genomics, S.A. |
2-(bicyclo-heteroaryl)-isonicotinic derivatives as histone demethylase inhibitors
|
|
US20200131129A1
(en)
|
2017-03-15 |
2020-04-30 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
CN110637011B
(zh)
|
2017-03-15 |
2024-05-14 |
奥加诺沃公司 |
法尼醇x受体激动剂及其用途
|
|
WO2018170165A1
(en)
|
2017-03-15 |
2018-09-20 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
WO2018210229A1
(zh)
|
2017-05-18 |
2018-11-22 |
南京明德新药研发股份有限公司 |
α-7尼古丁乙酰胆碱受体激动剂及应用
|
|
EP3668882A1
(en)
|
2017-08-18 |
2020-06-24 |
Cancer Research Technology Limited |
Pyrrolo[2,3-b]pyridine compounds and their use in the treatment of cancer
|
|
WO2019106087A1
(en)
|
2017-11-29 |
2019-06-06 |
Syddansk Universitet |
Ampk inhibitors
|
|
CA3118400A1
(en)
|
2017-12-01 |
2019-06-06 |
The Board Of Trustees Of The University Of Illinois |
Pyridinone-based epigenetic modifiers and uses thereof
|
|
CN111406054B
(zh)
|
2017-12-05 |
2024-01-02 |
奥莱松基因组股份有限公司 |
作为组蛋白脱乙酰基酶6抑制剂的1，2，4-噁二唑衍生物
|
|
WO2019158731A1
(en)
|
2018-02-16 |
2019-08-22 |
Ucb Biopharma Sprl |
Pharmaceutical 6,5 heterobicyclic ring derivatives
|
|
US10508113B2
(en)
|
2018-03-12 |
2019-12-17 |
Abbvie Inc. |
Inhibitors of tyrosine kinase 2 mediated signaling
|
|
AU2019243048A1
(en)
|
2018-03-27 |
2020-10-15 |
Ptc Therapeutics, Inc. |
Compounds for treating Huntington's disease
|
|
JP2019182784A
(ja)
|
2018-04-10 |
2019-10-24 |
大日本住友製薬株式会社 |
ジヒドロピラゾロピラジノン誘導体
|
|
EP3774775B8
(en)
|
2018-04-11 |
2023-11-15 |
VIIV Healthcare UK (No.5) Limited |
4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication
|
|
US11882759B2
(en)
|
2018-04-13 |
2024-01-23 |
Universal Display Corporation |
Organic electroluminescent materials and devices
|
|
JP7293343B2
(ja)
|
2018-05-09 |
2023-06-19 |
アプリノイア セラピューティクス リミテッド |
ヘテロアリール化合物及びその使用
|
|
EP3801503A4
(en)
|
2018-06-07 |
2021-12-08 |
Disarm Therapeutics, Inc. |
INHIBITORS OF SARM1
|
|
MA52813A
(fr)
|
2018-06-07 |
2021-04-14 |
Disarm Therapeutics Inc |
Inhibiteurs de sarm1
|
|
BR112021002408A2
(pt)
|
2018-08-09 |
2021-05-04 |
Valo Early Discovery, Inc. |
carboxamidas como inibidores da protease específica de ubiquitina
|